EUVIMEDEUVIMED entdecken
Crossref

Intratracheal Administration of Budesonide with Surfactant for Prevention of Death or Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants: A before–after Study

Anish Pillai iD, Nandkishor Kabra, Sharayu Kothavade, Anita Chevle, Sachin Sakharkar, Deepika Tiwari, Richa Choubey, Haribalakrishna Balasubramanian

American Journal of Perinatology · 01.08.2025 · 42 (11) · 1437-1444

DOI: 10.1055/a-2506-2893 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.08.2025. Verfasst von Anish Pillai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Surya Hospitals, Mumbai, Maharashtra, India. Hauptthemen laut MEDLINE: Budesonide, Bronchopulmonary Dysplasia, Pulmonary Surfactants, Infant, Extremely Low Birth Weight. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous studies have suggested a potential role for inhaled corticosteroids, such as budesonide, in reducing bronchopulmonary dysplasia (BPD) among preterm infants. The objective of our study was to investigate the effectiveness of intratracheal administration of corticosteroid with surfactant on the composite outcome of death or BPD at 36 weeks in extremely low birth weight (ELBW) infants. This before–after cohort study compared outcomes in ELBW infants with respiratory distress syndrome (RDS) who received intratracheal surfactant with budesonide to a historical cohort who received surfactant alone. Data were collected retrospectively for neonates in the surfactant group and prospectively for those receiving surfactant plus budesonide. A total of 385 ELBW infants were included. Death or BPD occurred in 123/203 (60.5%) in the surfactant with budesonide group versus 105/182 (57.6%) in the surfactant group; adjusted odds ratio 1.10 (95% CI: 0.69–1.75; p = 0.69). Statistical analysis revealed no significant difference in the incidence of the composite primary outcome (death or BPD at 36 weeks of postmenstrual gestational age), and its components, between the two study groups. In our study, coadministration of budesonide and surfactant was deemed safe and feasible among ELBW infants with RDS. However, we did not observe a significant reduction in the rates of composite or individual outcomes of death or BPD. Larger, randomized controlled trials are necessary to explore the potential advantages of this intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BudesonideBronchopulmonary DysplasiaPulmonary SurfactantsInfant, Extremely Low Birth WeightRespiratory Distress Syndrome, NewbornGlucocorticoidsHumansInfant, NewbornFemaleMaleRetrospective StudiesAdministration, InhalationGestational AgeProspective StudiesDrug Therapy, Combination

Substanzen

BudesonidePulmonary SurfactantsGlucocorticoids

Autor:innen und Institutionen

  • Department of Neonatology, Surya Hospitals, Mumbai, Maharashtra, India.
  • Department of Neonatology and Pediatrics, Motherhood Hospital, Navi Mumbai, Maharashtra, India.

ORCID-Profile: Anish Pillai

Zitieren

APA

Pillai, A., Kabra, N., Kothavade, S., Chevle, A., Sakharkar, S., Tiwari, D., Choubey, R., & Balasubramanian, H. (2025). Intratracheal Administration of Budesonide with Surfactant for Prevention of Death or Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants: A before–after Study. American Journal of Perinatology, 42(11), 1437-1444. https://doi.org/10.1055/a-2506-2893

Vancouver

Pillai A, Kabra N, Kothavade S, Chevle A, Sakharkar S, Tiwari D, et al. Intratracheal Administration of Budesonide with Surfactant for Prevention of Death or Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants: A before–after Study. American Journal of Perinatology. 2025;42(11):1437-1444. doi:10.1055/a-2506-2893

BibTeX
@article{Pillai2025,
  author = {Pillai, Anish and Kabra, Nandkishor and Kothavade, Sharayu and Chevle, Anita and Sakharkar, Sachin and Tiwari, Deepika and Choubey, Richa and Balasubramanian, Haribalakrishna},
  title = {Intratracheal Administration of Budesonide with Surfactant for Prevention of Death or Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants: A before–after Study},
  journal = {American Journal of Perinatology},
  year = {2025},
  volume = {42},
  number = {11},
  pages = {1437--1444},
  doi = {10.1055/a-2506-2893}
}
Kostenlos starten →